Clinical Trial

Ultrasonic Debris Clearance to Promote Brain Resilience

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This pilot study will evaluate the safety, tolerability, and feasibility of Ultrasonic Debris Clearance (UDC), a noninvasive low-intensity focused ultrasound intervention, in amyloid-positive adults who are asymptomatic but at risk for Alzheimer's disease, or who have mild cognitive impairment or mild dementia. The study is designed to test whether repeated UDC sessions can be delivered safely and feasibly in this population, while also exploring efficacy via biomarkers and clinical measures.
Trial Details
NCT Number NCT07573982
Lead Sponsor Stanford University
Conditions Alzheimer s Disease, MCI With Increased Risk for Alzheimer Disease
Enrollment 15 participants
Start Date 2026-07
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-07